BackAbbott Laboratories Overview
Abbott Laboratories

Abbott Laboratories Target Price

See Abbott Laboratories's analyst price targets ($120) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$101.96

Average Target Price

$122.8620.5% upside

7 analysts in the last 4 months

High: $134 | Low: $112

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Wolfe Research$13027.5% upsideOpen
2026-07-28UBSPatrick Wood$12522.6% upsideOpen
2026-07-20Benchmark Co.$12017.7% upsideOpen
2026-07-17Piper Sandler$11815.7% upsideOpen
2026-07-16BTIG$13431.4% upsideOpen
2026-07-06Evercore ISIVijay Kumar$1129.8% upsideOpen
2026-06-30Robert W. BairdDavid Rescott$12118.7% upsideOpen
2026-04-22Daiwa$929.8% downsideOpen
2026-04-20BarclaysMatt Miksic$14340.3% upsideOpen
2026-04-17UBS$11512.8% upsideOpen
2026-04-17Piper Sandler$11512.8% upsideOpen
2026-04-17Stifel Nicolaus$12017.7% upsideOpen
2026-03-13UBSDanielle Antalffy$15855% upsideOpen
2026-03-13New Street$14542.2% upsideOpen
2026-02-02Barclays$14239.3% upsideOpen
2026-01-29Loop Capital MarketsIlya Zubkov$12017.7% upsideOpen
2026-01-23Evercore ISI$13835.3% upsideOpen
2026-01-23UBS$13229.5% upsideOpen
2026-01-23Mizuho SecuritiesAnthony Petrone$12522.6% upsideOpen
2026-01-23Piper Sandler$13532.4% upsideOpen
2026-01-23Bernstein$12522.6% upsideOpen
2026-01-23Wells FargoLarry Biegelsen$12219.7% upsideOpen
2026-01-09BernsteinLee Hambright$15451% upsideOpen
2026-01-09Goldman Sachs$15249.1% upsideOpen
2026-01-05Evercore ISI$14441.2% upsideOpen
2026-01-05Barclays$16965.8% upsideOpen
2025-12-22BTIGMarie Thibault$14542.2% upsideOpen
2025-11-21Tigress Financial$14542.2% upsideOpen
2025-10-17Barclays$16258.9% upsideOpen
2025-10-16Wells Fargo$14643.2% upsideOpen
2025-10-01Goldman Sachs$15754% upsideOpen
2025-07-15RBC CapitalShagun Singh$14744.2% upsideOpen
2025-04-15RBC CapitalShagun Singh$14037.3% upsideOpen
2025-01-08BernsteinLee Hambright$13532.4% upsideOpen
2024-10-17Piper SandlerAdam Maeder$13330.4% upsideOpen
2024-10-17BernsteinLee Hambright$13835.3% upsideOpen
2024-10-16JefferiesMatthew Taylor$12522.6% upsideOpen
2024-10-16Evercore ISIVijay Kumar$12825.5% upsideOpen
2024-10-16BTIGMarie Thibault$13936.3% upsideOpen
2024-10-08OppenheimerSuraj Kalia$13027.5% upsideOpen
2024-10-08SusquehannaCharles Minervino$12017.7% upsideOpen
2024-10-08RBC CapitalShagun Singh$13027.5% upsideOpen
2024-09-19Roth CapitalScott Fortune$24.0176.5% downsideOpen
2024-09-19RBC CapitalJonathan Atkin$165.6562.5% upsideOpen
2024-09-19Piper SandlerAdam Maeder$13128.5% upsideOpen
2024-08-27JefferiesMatthew Taylor$12017.7% upsideOpen
2024-08-22CitigroupJoanne Wuensch$12724.6% upsideOpen
2024-07-18CitigroupJoanna Wiensch$11916.7% upsideOpen
2024-07-18Raymond JamesJayson Bedford$12724.6% upsideOpen
2024-07-02Evercore ISIVijay Kumar$12017.7% upsideOpen

Abbott Laboratories (ABT) FAQ

The latest target price for ABT is $120. Investors often review this figure alongside Abbott Laboratories's historical trend and sector peers before judging valuation or financial health.

Abbott Laboratories trades near $101.96 while the consensus target sits at $120 (20.5% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ABT's target price ($120), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Abbott Laboratories's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.